E&Investment, Inc.

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Seoul, Korea, Republic of
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ E&I Investment, Inc., By: Na Yeon Kim, CEO
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for E&Investment, Inc.

Form 4 holding 10%+ Owner

NeuroBo Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
2,890,533
Estimated value
$9,047,368
Report date
26 Jul 2022
Price
$3.13
Ownership
Held by The E&Healthcare Investment Fund II
Form 4 holding 10%+ Owner

NeuroBo Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
1,864,799
Estimated value
$5,836,821
Report date
26 Jul 2022
Price
$3.13
Ownership
Held by The E&Healthcare Investment Fund No. 7
Form 4 holding 10%+ Owner

NeuroBo Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
1,121,190
Estimated value
$3,509,325
Report date
26 Jul 2022
Price
$3.13
Ownership
Held by The E&Healthcare Investment Fund No. 6

Insider Reports Filed by E&Investment, Inc.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .